The global amniotic membrane market was valued at $812 million in 2016, and is expected to reach $1,563 million by 2023, registering a CAGR of 9.7% during the forecast period. Amniotic membrane is the innermost layer of the placenta, which consists of a thick basement membrane and an avascular stromal matrix. It can be used as a graft and as a dressing to ease ocular surface reconstruction and promote healing for various ailments.
The major factors that drive the growth of the amniotic membrane market is the rise geriatric population coupled with the increase in amniotic membrane based transplantation globally. However, dearth of skilled professionals and high cost of the surgeries involving amniotic membrane restrain the growth of the global amniotic membrane market. Moreover, the increase in awareness regarding the potential benefits of amniotic membrane among the patients as well as the healthcare professionals offers lucrative opportunities that boost the market.
The global amniotic membrane market is segmented based on product, application, end user, and region. Based on product, the market is bifurcated into cryopreserved amniotic membrane and lyophilization amniotic membrane. Based on application, it is divided into surgical wounds, ophthalmology, and others. Based on end user, itis classified into hospitals, ambulatory surgical centers, specialized clinics, and research centers & laboratory. Based on region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided.
Comprehensive quantitative analysis of the industry from 2016 to 2023 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the type of amniotic membrane used globally.
Key market players and their strategies are provided to understand the competitive outlook of the market.
KEY MARKET SEGMENTS
By Product
Cryopreserved Amniotic Membrane
Lyophilization Amniotic Membrane
By Application
Surgical Wounds
Ophthalmology
Others
By End User
Hospitals
Ambulatory Surgical Centers
Specialized Clinics
Research Centers & Laboratory
By Region
North America
U.S.
Canada
Mexico
Europe
Asia-Pacific
LAMEA
KEY PLAYERS PROFILED
FzioMed, Inc.
Skye Biologics Inc.
IOP Ophthalmics
Amniox Medical, Inc.
Amnio Technology, LLC
Applied Biologics LLC
Alliqua BioMedical, Inc
Human Regenerative Technologies, LLC
Derma Sciences Inc
MiMedx Group, Inc
